Encyclopedia

  • The pregnant ovine endometrium constitutively expresses and secretes a highly stable bombesin-like peptide, which shares C-terminal sequence but differs structurally from gastrin-releasing peptide
  • Add time:08/09/2019         Source:sciencedirect.com

    Previous studies have shown that a peptide closely related to gastrin releasing peptide (GRP) is expressed by the pregnant ovine endometrium throughout gestation, however its molecular form and the mode of its secretion have not been defined. We have partially purified the endometrial GRP-Like peptide and characterised it chromatographically. In contrast to other tissues, the main molecular form of endometrial GRP is larger (6–8 kDa versus 1–3 kDa), and based on the increased hydrophobicity of its circulating form after reduction, contains at least one disulfide bond. Reduction and treatment with chaotropic agents showed that the protein is not a cleavage product of pro-GRP bound to a binding protein. Tryptic cleavage demonstrated that the C-terminus of the peptide is closely related to GRP18–27 suggesting that bioactivity is likely. The partially purified peptide remained intact after incubation in ovine plasma for 16 h indicating that it is extremely stable and consistent with an hormonal role during pregnancy. Quantification of peptide from monolayer cultures of ovine endometrial cells showed that the GRP-like peptide was secreted constitutively. These data show that a stable, GRP-like peptide, distinct from the known processing products of pre-pro-GRP is constitutively expressed by the gravid ovine endometrium. Since endometrial GRP has an intact bioactive C-terminus and is mitogenic for numerous tissues including the uterus, then it is likely to play an important regulatory role in ovine pregnancy.

    We also recommend Trading Suppliers and Manufacturers of bombesin (6-14), Nal(6)-Psi(13,14)-Phe(14)- (cas 123770-00-3). Pls Click Website Link as below: cas 123770-00-3 suppliers


    Prev:Preparation and characterization of CefquinoMe sulfate (cas 123766-80-3) microparticles for transdermal delivery by negative-pressure cavitation antisolvent precipitation
    Next: Selective reduction of 4-substituted 3-aryl-5-trifluoromethylisoxazole by NaBH4)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View